UNICEF- Update on key activities and plans IPC, 5 th -6 th June. 2014.

Slides:



Advertisements
Similar presentations
Scaling-up the UNDP-UNEP Poverty and Environment Initiative January 2007 environment for the MDGs.
Advertisements

A Call to Action Children – The missing face of AIDS.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
UNICEF Supply Division GMMM Geneva, Switzerland March 2011 Vaccine Supply Update – UNICEF’s role at global level.
Brazzaville, Congo 5-7 March 2014
Childhood Pneumonia and Diarrhoea 3 Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia.
Bobby Jefferson Senior HMIS Advisor Futures Group The Site Capacity Assessment (SCA) Tool and other Mechanisms to Monitor Transition Status Track 1 Implementers.
Pre Tender Meeting UNICEF Supply Division, December 2008 Rob Matthews UNICEF Vaccine Procurement for Developing Countries.
Development Effectiveness in a world of targeted aid: the contribution of the Global Fund Dr. Viviana Mangiaterra Senior Coordinator, RMNCH and HSS Technical,
UNICEF Supply Division, Copenhagen, June 2015
MINISTRY OF COMMUNITY DEVELOPMENT MOTHER AND CHILD HEALTH MRS. ELIKA KAMIJI CHIEF EPI OFFICER IMPLEMENTATION OF GAPPD: ZAMBIAN EXPERIENCE Global Immunization.
UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
Measles Partnership Meeting Yalda Momeni September 23 rd - WDC.
Roll Back Malaria Monitoring & Evaluation Reference Group (MERG) RBM 12 th Partnership Board Meeting Geneva, May 10-11, 2007 Bernard Nahlen Bernard Nahlen.
PROCUREMENT SUPPORT SERVICE WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November 1 st -5 th 2010 Mariatou Tala Jallow, Manager,
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
APPMG BEAD meeting London, February 6, 2006 MALARIA VACCINES DEVELOPMENT: THE WAY AHEAD Joe Cohen, Ph.D. Vice President R&D Vaccines for Emerging Diseases.
WHO Health Care Waste Management Protection of the Human Environment (PHE) Injection Safety Best Practices – Waste Management Richard M Carr.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Outline Background Objectives and activities GPEI assets
AMFm Overview and Case Management Observations RBM Case Management Working Group (CMWG)
GAVI/Vaccine Fund Support to Improve Injection Safety On behalf of the Injection Safety sub-group.
DRAFT V1 National Vaccine Supply Chain Innovations: Country Commitment to Ownership, Sustainability & Impact GAVI Partners’ Forum WHO – UNICEF – GAVI -
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Measles Initiative Management and Financing September 13, 2011.
Existing Challenges – POC Introduction Lab Technical Working Group Jason Williams, Principal Laboratory Advisor, SCMS January 20-21, 2013.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Measles Partnership Meeting Update on Vaccine Supply Washington, 27-28th February 2007 UNICEF Supply Division.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
1 SUPPLY DIVISION Procurement and Supply Management Technical Assistance.
Working Draft - Last Modified :21:46 Printed UNITAID action plan - pediatric TB 0 “Securing timely access to quality, affordable TB drugs”
Evolution to date: where the clusters have come from, where have we reached and where should we be heading? GNC Annual Meeting 13 th -15 th October, Nairobi,
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Agenda Introduction- Jessica Rodrigues, IATT Paediatric Treatment Optimization- George Silberry, Senior Technical Advisor for Pediatric HIV, OGAC Optimal.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Interagency Pharmaceutical Coordination Group Hitesh Hurkchand RMNCH Strategy and Coordination Team Liliane Kandeh and her son picking up their malaria.
INNOVATIVE FINANCE: HELPING SAVE MORE LIVES Paolo Sison Director, Innovative Finance Tbilisi International Solidarity and Innovative Financing.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
LFA PSM expert workshop January 2014 Strategies for supporting the rational scale-up of laboratory monitoring of HIV.
February 2015 An introduction to the switch from trivalent to bivalent oral polio vaccines 1.
THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.
Global Fund Work on HIV/SRH Linkages 09 March 2015 Olga Bornemisza New York, USA IAWG Meeting on HIV/SRH Linkages.
GFF Third Investors Group Meeting Geneva, Switzerland June 23-24, 2016 Financing for RMNCAH: complementary financing Global Fund’s engagement with the.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Maternal and Child Survival Program/JSI
Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.
Integrated PSM for effective ICCM implementation
Measles Containing Vaccines
Access framework HIV/AIDS, TB and Malaria
World Health Organization
World Health Organization
AMDS Products, events and issues.
Access to HIV/AIDS Medicines The 3x5 strategy
Ministry of Health, Kenya
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Multi-disease diagnostic integration
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Presentation transcript:

UNICEF- Update on key activities and plans IPC, 5 th -6 th June. 2014

Procurement in support of programmes Supplies and services for 134 countries and areas Total procured $2,839 Emergency $127 Supplies to 33 countries and areas Procurement Services $1,363 Supplies to 99 countries

Supplier and destination countries

Medicines: 2014 Activities Procurement strategies to address increasing demand for priority medicines: ORS/Zinc, amoxicillin DT, gentamicin, CHX, dexamethasone inj, IFA… Support work of UNCLSC and Pneumonia and Diarrhoea WG: Amoxi DT ERP, availability of medicines and diagnostics, collaboration to increase sources, country implementation including activities resulting from GF/UNICEF MoU. Optimization of kits: iCCM (DRC), Diarrhoea kit, PEP Kit Partnerships to ensure availability of pediatric ARVs: IATT Formulary development Pediatric ARV WG Pediatric ARV Procurement Working Group Controlled temperature shipments Improve internal process and supplier relations to provide optimal service

The market dashboard Inspired from UNITAID Market dynamics Dashboard The Dashboard monitors the market dynamics of more than 50 essential commodities for women and children. It provides a qualitative assessment of the determinants of a healthy market, including: Availability Affordability Competition Quality Acceptability Delivery Funding security Published twice a year, aim is to encourage internal and collaborative thinking on ways to address gaps and achieve a more balanced market

ORS/Zinc co-pack: 3 LTAs established, first procurement of over 200K packs Chlohexidine 4% for umbilical cord care: collaboration through UNCLSC to increase number of manufacturers and qualify gel formulations. Amoxicillin DT: increase in demand and initiation of substitution of suspension Introduction of optimal products

Kit delivery Majority are health kits

Supply of commodities to manage sexual assault of children and women in the context of emergencies Challenges Forecasting the need Kit design not addressing diversity of situations where it is used (target, skills and care services) Repacking of kits at Country Office level to meet needs Split up kit contents to distribute to smaller health facilities Split up blisters/packs to dispense to patients Specific needs of children usually not taken care of, e.g. paediatric dosages Lack of specific Guidance PEP Children PEP Adults Wound Care Psychosocial Support Associated Conditions + Guidance Documents Proposed Response (for discussion with partners) Easy identification of the necessary items for management of sexual assault More flexibility in procurement of PEP for children Holistic response, Clear guidance Guidelines to be reviewed 2014 (WHO)

Consolidate regimens used Consolidate formulations used Ensure pediatric ART guidelines are up to date Identify regimens and products that can be phased out of formulary (eg. d4T, ddI) Review current procurement list for redundancies Explore areas for transition to optimal products such as FDC’s and phase out suboptimal or redundant formulations Partnerships to ensure availability of optimal treatment for HIV in children Consolidate formulations used Coordinate pediatric ARV procurement amongst partners Align both supply and demand to more efficient products. Interagency Task Team (IATT)/ Pediatric ARV Working Group Pediatric ARV Procurement Working Group/ Buyer Consortium

Health Technology Centre Essential supplies for Health Programmes Medical equipment and consumables, diagnostics tests and clinical laboratory equipment Long Lasting Insecticide treated bed nets ( LLIN’s), Insecticides and Rapid Tests Malaria Prevention and Diagnostics Medical Devices and Laboratory Cold Chain Cold chain equipment, refrigerators, waste disposal, injection safety devices Maternal and New born Health Issues INNOVATION FOCUS Injection safety devices, waste disposal. Immunisation Devices

Health Technology: 2014 Activities Optimization strategies defined for Health Technologies Supply Chains,.i.e. Performance indicators, Forecasting, Shipments optimization and Total Landed Cost options Quality policies prepared, harmonization with key partners (IVD, High Risk Medical Devices, mapping high-risk products that could be those correspond to class IIB and III of European MDD and develop its risk mitigation protocol). Innovation – ARIDA project ( pneumonia diagnostics ), in collaboration with WHO, Malaria Consortium, BMGF Partnerships LLIN procurement – GF, UNDP, DfiD, PMI, Partnerships POC technology – UNITAID, CHAI, 7 countries

Ensure a cold chain for all TTSPP …. Scale up of old vaccines ……. Scale up of new vaccines …… Scale up of new versions such as IPV …. Healthy market for innovative cold chain equipment Supply Chain integration – Oxytocin, Insulin Cold chains for lab samples, blood banks, test kits … Immunization devices available for all Optimizing immunization shipments/cost per device delivered Untangling the web of quality requirements Waste management for immunization, diagnostic testing ? Aligning with WHO PQS for injection safety devices procurement and providing feedback on evaluation protocols and technical specifications Contribute to the updating of WHO guideline of injection safety Activities

UNICEF-CHAI Project: Accelerate Access to Innovative Point of Care (PoC) HIV Diagnostics: CD4, Early Infant Diagnosis, and Viral Load Funded by UNITAID Targets: 7 focus countries Zimbabwe, Tanzania, Kenya, Ethiopia, Uganda, Mozambique, Malawi Programmatic and Supply coverage: CD4 testing, which is used for staging and monitoring HIV patients prior to initiation onto antiretroviral therapy (ART). Early Infant Diagnosis (EID) testing for infants less than 18 months of age (this technology can be performed on viral load platforms as well). Viral Load (VL) testing, which is mainly used for monitoring HIV patients following initiation to ART UNICEF Quality Policy for procurement of IVDs consulted with WHO, CDC, MSF and fully harmonized with Global Fund. Phase 1 Nov 2012-December June 2014 US$ 20million Phase 2a Project proposal approved and MOU currently under negotiations Period July 2014 –Dec 2015 US$ 35million Phase2b Project ending 2018 funding remains subject to UNITAID board approval

Source: UNIICEF Supply Division Immunization Supplies Vaccines BCG, DTP, TT/Td/DT, Measles containing, OPV, HepB, YF, DTP-HepB, DTP-HepB/Hib, DTP/Hib, Hib, MR, Meningitis, MMR, PCV, RV IPV, HPV etc. Safe Injection equipment Cold Chain Equipment Vaccines BCG, DTP, TT/Td/DT, Measles containing, OPV, HepB, YF, DTP-HepB, DTP-HepB/Hib, DTP/Hib, Hib, MR, Meningitis, MMR, PCV, RV IPV, HPV etc. Safe Injection equipment Cold Chain Equipment Vaccines Supplies: US$ 1, 285 million 2.79 billion doses 2,185 shipments 2013 Countries UNICEF procures on behalf of Full schedule Partial schedule UNICEF has a key role in vaccine procurement, procuring immunization supplies on behalf of around 100 countries annually Source UNICEF Supply Division

Vaccines: 2014 Activities*  Support to countries / on-going operations: Coordination internally and support to countries for high number of new vaccine introductions (79 new vaccine introductions (13 IPV) in GAVI supported countries in 2014; 123 (59 IPV) in 2015), and continuing programmes; specific innovative projects follow up: VAR, Visual Vaccines; KPIs  Continued/increased support to MICs and GAVI graduating countries through procurement practitioners forum to support countries moving to self-procurement, review VII and other financing mechanisms, engagement with partners and countries, MIC tender for new vaccines  Polio eradication – IPV tender concluded in Q and operationalized during the year; OPV supply and demand planning for vaccines and funding; strategy for type 2 withdrawal  Timely completion of tender activities and additional awards (JE, Mening, penta, HPV, PCV, Rota); develop consolidated strategy for achieving price goals  Provide more useful and accessible information for countries, manufacturers and partners (eg, update website, pricing data, procurement contexts, market updates)  Continue to strengthen supplier relationships, including at least 1 visit to each of the top 10 suppliers and visit to China  Follow-up with DRC and Nigeria on supply chain optimization projects  Coordination with partners, including GAVI, BMGF, WHO, GPEI, etc *Key activities, not all inclusive

Virus detection & interruption Last wild polio caseCertification RI strengthening & OPV withdrawal Containment & certification Introduce IPV Wild virus interruption Outbreak response (esp. cVDPVs) RI strengthening & OPV2 pre-requisites OPV2 withdrawal Legacy Planning Finalize long-term containment plans Complete containment & certification globally Consultation & strategic plan Initiate implementation of legacy plan Last OPV2 use Endgame Major Objectives Source: WHO

WHA endorsement in 2013 of Endgame Strategy require IPV introductions in 123 countries globally within 20 months

Sufficient supply secured to meet projected demand through UNICEF at affordable prices, but planning needed 20 countries requiring supply in 2014, with 7 planned introductions A total of 75 countries to introduce in this period, and two continuing countries 20 LMIC/MIC countries to continue or introduce sourcing through UNICEF Flexibility required with regards to product preferences, number of shipments per year, delivery of buffer stocks, month of introduction, registration requirements

UNICEF support to the tOPV/bOPV switch Global synchronized switch from tOPV to bOPV requires careful planning at global and country level Engagement with partners, countries, and industry to ensure smooth transition and no shortages of any product Protocols and strategies under development for operationalization of a switch

Vaccines stock monitoring and projection tool… ViVa (Visibility for Vaccines) …Enabling identification and communication of upcoming potential constraints linked to supply through graphs. From May to August 2014: Pilot phase with EPI in DRC, Niger and Senegal. Next: Feedback interest survey and decision on continuity and scaling-up.

Supporting Middle Income Countries to Access New Vaccines For additional information on UNICEF’s MIC New Vaccine Procurement Initiative see UNICEF Vaccine Procurement Practitioners Forum (Q4 2014) EURO Inter-country Vaccine Procurement Workshop 2013 Transition planning for GAVI graduating countries Vaccine Procurement System Assessments Coordination of MIC support with global/regional partner activities: Global MIC Task Force Vaccine Product, Price and Procurement (V3P) Project EMRO Pooled Vaccine Procurement (PVP) initiative GAVI support for access to appropriate pricing for graduates & other LMICs Sharing of knowledge of (i) the vaccine market, (ii) Vaccine Security and underlying elements of forecasting, funding and appropriate contracting, (iii) vaccine procurement. Issue market analyses. Publish Reference Prices to serve as a benchmark for self- procuring MICs. Aggregate MIC demand forecasts for new vaccines to provide better visibility to industry. Pool MICs’ vaccine procurement to improve demand predictability, reduce transaction costs and improve pricing. MIC Pooled Procurement Information Access Capacity Building Technical Assistance Strategic Partnerships

Some countries where we are already working with the govt to strengthen the supply chain and develop capacity DRC Immunization and Essential Medicines Nigeria Immunization Sierra Leone All Health Commodities Kenya Essential medicines Zambia Essential Medicines Afghanistan Immunization Madagascar Essential Medicines Myanmar All Health Commodities Eritrea Education Ethiopia Essential Medicines Niger Essential Medicines and Nutrition Tanzania Essential Medicines Cote d’Ivoire Bednets Malawi All Health Commodities Mozambique All Health Commodities

2014 Activities  Support to development and implementation of national supply chain strategies  Global networking and collaboration (GAVI, Global Fund, RBM etc.)  Communication strategy and advocacy tools to raise awareness internally and externally  Research to increase understanding of national supply chain models and promising practices  Guidelines for capacity development with a supply chain toolkit for COs and partners (including a SC health check and performance monitoring tools)  Roster of consultants for technical assistance  Support development of the supply community technical skills framework and professional development plan  Develop the Global Learning Centre Strategy including the initial curriculum (starting with vaccines, bednets and nutrition)  South to south exchanges

What does success look like in 2017?  Increased use of national supply chains, from determination of need through to delivery to the last mile, across all programmes and including monitoring  Increased number of countries actively implementing national supply chain strategies, led by government  Strong networks created with increased collaboration, sharing and co-ordination in capacity development and supply chain systems strengthening initiatives at global, regional and country level  At least 20 government supply chains strengthened and optimized for targeted products